Hosseini Saeid, Kashfi Fahimeh, Samiei Niloufar, Khamoushi Amirjamshid, Ghavidel Alireza Alizadeh, Yazdanian Forouzan, Mirmesdagh Yalda, Mestres Carlos A
J Heart Valve Dis. 2015 Mar;24(2):253-9.
Cardiac surgery during pregnancy is rarely required and potentially increases feto-maternal mortality. The study aim was to evaluate pregnancy outcomes in females who underwent open-heart surgery with cardiopulmonary bypass (CPB) during pregnancy.
Between 1999 and 2014, a total of 16 pregnant women (mean age 27 ± 7 years; mean gestational age 13 ± 7.7 weeks) underwent urgent cardiac surgery using CPB. The preoperative diagnosis included prosthetic valve dysfunction in 12 women (five aortic, seven mitral), native valve endocarditis and critical aortic stenosis each in one woman, and intracardiac masses in two women. Eleven patients were in the first trimester, three in the second trimester, and two in the third trimester. A retrospective analysis was conducted that included maternal variables of age, gestational age, cardiac diagnosis, prior operations, surgical details, maternal morbidity and mortality and type of delivery, while fetal variables included incidence of low birth weight, prematurity, and fetal malformation. Patients were allocated to two groups: Group A (n = 9) included pregnant women with living neonates, while group B (n = 7) included pregnant women with an aborted fetus or dead neonate. All data were compared between the groups.
There was no in-hospital maternal mortality. There were no significant differences between the two groups regarding age, gestational age, previous cardiac operation, type of surgery, duration of operation, perfusion pressure and core temperature during CPB. The CPB time was longer in group B (110.3 ± 57.1 min) than in group A (62 ± 15.7 min) (p = 0.028), as was the aortic cross-clamp time (54.3 ± 27.2 min and 38.7 ± 9.3 min in groups A and B, respectively) (p = 0.014). Group B patients received higher doses of inotropes perioperatively. No congenital abnormalities were identified in any of the living neonates.
The durations of CPB and aortic cross-clamping may not affect maternal outcome, but shorter CPB and aortic cross-clamp times led to better fetal outcomes. Increasing the perioperative dosage of inotropes may lead to a reduced fetal survival.
孕期心脏手术需求极少,且可能增加母婴死亡率。本研究旨在评估孕期接受体外循环(CPB)心脏直视手术的女性的妊娠结局。
1999年至2014年间,共有16名孕妇(平均年龄27±7岁;平均孕周13±7.7周)接受了使用CPB的紧急心脏手术。术前诊断包括12名女性人工瓣膜功能障碍(5例主动脉瓣、7例二尖瓣)、1名女性原发性瓣膜心内膜炎和严重主动脉瓣狭窄、2名女性心内肿物。11例患者处于孕早期,3例处于孕中期,2例处于孕晚期。进行了一项回顾性分析,包括产妇的年龄、孕周、心脏诊断、既往手术史、手术细节、产妇发病率和死亡率以及分娩类型等变量,而胎儿变量包括低出生体重、早产和胎儿畸形的发生率。患者被分为两组:A组(n = 9)包括有存活新生儿的孕妇,B组(n = 7)包括胎儿流产或新生儿死亡的孕妇。对两组间的所有数据进行了比较。
住院期间无产妇死亡。两组在年龄、孕周、既往心脏手术、手术类型、手术时间、CPB期间的灌注压力和核心温度方面无显著差异。B组的CPB时间(110.3±57.1分钟)长于A组(62±15.7分钟)(p = 0.028),主动脉阻断时间也是如此(A组和B组分别为54.3±27.2分钟和38.7±9.3分钟)(p = 0.014)。B组患者围手术期接受了更高剂量的正性肌力药物。在任何存活新生儿中均未发现先天性异常。
CPB和主动脉阻断时间可能不影响产妇结局,但较短的CPB和主动脉阻断时间可带来更好的胎儿结局。增加围手术期正性肌力药物剂量可能导致胎儿存活率降低。